semaglutide and alcohol nausea Alcohol: What's Safe and What to Avoid semaglutide #glp1 #alcoholusedisorder #addictionmedicine #obesity

A clinical trial showed that with Wegovy, the major adverse cardiovascular events (heart attack, stroke, cardiovascular death) can be reduced by 20% in specific patients with heart disease

There is limited peer-reviewed evidence specifically studying GLP-1 microdosing for weight management

The five-year EPS growth rate of 45% per year confirms Lilly is compounding at a pace that few companies at this scale can match

Working with your provider to step down on the dosage which you were able to tolerate or switching medications, as needed, would be my recommendation

If someone walks into your office with heart disease and you as a physician dont try to treat it, thats malpractice, Seeley says

Pharmaceutical companies are working on innovative formulations, improved bioavailability, combination treatments, and modes of administration